Partial Seizures Clinical Trial
Official title:
Pregabalin Add-On Titration Trial: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Pregabalin (150 mg - 600 mg/Day) Using a Flexible, Optimized Dose Schedule in Subjects With Partial Seizures
To evaluate the efficacy of pregabalin as adjunctive therapy, using a flexible, optimized dose schedule with dose adjustment based on clinical response and tolerability, compared to placebo in subjects with partial seizures
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01954121 -
Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures
|
Phase 3 | |
Completed |
NCT01630057 -
Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug
|
Phase 4 | |
Completed |
NCT00327717 -
Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures
|
Phase 3 | |
Completed |
NCT00537238 -
Pregabalin Versus Levetiracetam In Partial Seizures
|
Phase 3 | |
Completed |
NCT03340064 -
A Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age
|
Phase 3 | |
Terminated |
NCT00407797 -
Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial
|
Phase 4 | |
Completed |
NCT01136954 -
A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)
|
Phase 3 | |
Completed |
NCT04257604 -
A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures
|
||
Completed |
NCT01392768 -
Efficacy and Safety of Levetiracetam in Partial Seizures Control, With or Without Secondary Generalization
|
Phase 3 | |
Completed |
NCT01063764 -
An Open Label Study of Levetiracetam in Japanese Pediatric Patients With Partial Seizures
|
Phase 3 | |
Completed |
NCT00102713 -
A Study for Treatment of Partial Seizures in Children
|
Phase 3 | |
Completed |
NCT01262677 -
Once-A-Day Pregabalin For Partial Seizures
|
Phase 3 |